Medicare patients admitted to hospitals with higher readmission rates are more likely to have characteristics associated with a higher probability of readmission, according to a study published online today by JAMA Internal Medicine. “This finding suggests that Medicare is penalizing hospitals to a large extent based on the patients they serve,” the study concludes. The authors found 22 patient characteristics that significantly predicted readmission when added to standard Hospital Readmissions Reduction Program adjustments of hospital readmission rates, and 17 of these were distributed differently between hospitals in the highest and lowest quintiles of publicly reported readmission rates. For example, patients admitted to the highest quartile had more chronic conditions, less education, fewer assets, worse self-reported health status, more depressive symptoms, worse cognition and physical functioning, and more difficulties with daily living activities. The difference in readmission risk between hospitals in the highest and lowest quintiles fell by 48% after adjusting for all patient characteristics assessed. For more on the study, see today’s AHASTAT blog post.

Related News Articles

Headline
ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and…
Headline
A study published today by Nature found that as many as 5,000 steps per day can slow cognitive decline for individuals with early signs of Alzheimer’s disease…
Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…
Blog
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…